| Product Code: ETC8558543 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, New Zealand saw steady growth in dog and cat drug compounding imports, with key exporting countries being Australia, Metropolitan France, Spain, Ireland, and Germany. The market displayed low concentration levels according to the Herfindahl-Hirschman Index (HHI). Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period from 2020 to 2024 remained positive at 3.11%. This indicates a stable market with diverse sources of imports, pointing towards a continued demand for specialized medications for pets in New Zealand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Dog and Cat Drug Compounding Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, 2022 & 2032F |
3.3 New Zealand Dog and Cat Drug Compounding Market - Industry Life Cycle |
3.4 New Zealand Dog and Cat Drug Compounding Market - Porter's Five Forces |
3.5 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume Share, By Dosages Form, 2022 & 2032F |
3.7 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume Share, By Animal Type, 2022 & 2032F |
4 New Zealand Dog and Cat Drug Compounding Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership in New Zealand |
4.2.2 Rising awareness about personalized medicine for pets |
4.2.3 Growing demand for specialized veterinary care |
4.3 Market Restraints |
4.3.1 Stringent regulations related to compounding drugs for animals |
4.3.2 Limited availability of skilled professionals in drug compounding for pets |
4.3.3 Competition from established pharmaceutical companies |
5 New Zealand Dog and Cat Drug Compounding Market Trends |
6 New Zealand Dog and Cat Drug Compounding Market, By Types |
6.1 New Zealand Dog and Cat Drug Compounding Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Anti-infective Drugs, 2022 - 2032F |
6.1.4 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Anti-inflammatory Drugs, 2022 - 2032F |
6.1.5 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By CNS Agents, 2022 - 2032F |
6.1.6 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By GI Drugs, 2022 - 2032F |
6.1.7 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 New Zealand Dog and Cat Drug Compounding Market, By Dosages Form |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Tablets & Capsules, 2022 - 2032F |
6.2.3 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Powder, 2022 - 2032F |
6.2.4 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Solution, 2022 - 2032F |
6.2.5 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 New Zealand Dog and Cat Drug Compounding Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Oral, 2022 - 2032F |
6.3.3 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.3.4 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Topical, 2022 - 2032F |
6.3.5 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 New Zealand Dog and Cat Drug Compounding Market, By Animal Type |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Dog, 2022 - 2032F |
6.4.3 New Zealand Dog and Cat Drug Compounding Market Revenues & Volume, By Cat, 2022 - 2032F |
7 New Zealand Dog and Cat Drug Compounding Market Import-Export Trade Statistics |
7.1 New Zealand Dog and Cat Drug Compounding Market Export to Major Countries |
7.2 New Zealand Dog and Cat Drug Compounding Market Imports from Major Countries |
8 New Zealand Dog and Cat Drug Compounding Market Key Performance Indicators |
8.1 Average turnaround time for drug compounding orders |
8.2 Customer satisfaction rates with personalized drug formulations |
8.3 Number of veterinary clinics offering drug compounding services |
9 New Zealand Dog and Cat Drug Compounding Market - Opportunity Assessment |
9.1 New Zealand Dog and Cat Drug Compounding Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 New Zealand Dog and Cat Drug Compounding Market Opportunity Assessment, By Dosages Form, 2022 & 2032F |
9.3 New Zealand Dog and Cat Drug Compounding Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 New Zealand Dog and Cat Drug Compounding Market Opportunity Assessment, By Animal Type, 2022 & 2032F |
10 New Zealand Dog and Cat Drug Compounding Market - Competitive Landscape |
10.1 New Zealand Dog and Cat Drug Compounding Market Revenue Share, By Companies, 2025 |
10.2 New Zealand Dog and Cat Drug Compounding Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here